A randomized study of cyclophosphamide and cis-platinum with or without doxorubicin in advanced ovarian carcinoma
- 1 October 1987
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 28 (2) , 161-169
- https://doi.org/10.1016/0090-8258(87)90210-1
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer.Journal of Clinical Oncology, 1986
- A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A gynecologic oncology group studyCancer, 1986
- Common Epithelial Cancer of the OvaryNew England Journal of Medicine, 1985
- RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1984
- Current status of systemic chemotherapy in the treatment of advanced ovarian cancer with emphasis on CHAP-5Radiotherapy and Oncology, 1984
- Long-term survival after chemotherapy for advanced epithelial ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1984
- Cisplatin regimens and improved prognosis of patients with poorly differentiated ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1983
- RANDOMISED TRIAL COMPARING LOW-DOSE CISPLATIN AND CHLORAMBUCIL WITH LOW-DOSE CISPLATIN, CHLORAMBUCIL, AND DOXORUBICIN IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1981
- Radiation therapy in stage II ovarian carcinoma. The influence of histologic gradeCancer, 1980